A business in context
AMGN research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-08-13 | Khosla Rachna | S · Sale | Common Stock | 1252.0 | 416.43 |
| 2026-08-13 | Khosla Rachna | M · Exercise / conversion | Common Stock | 1252.0 | 162.6 |
| 2026-08-13 | Khosla Rachna | M · Exercise / conversion | Nqso (Right to Buy) | 1252.0 | 0.0 |
| 2026-08-11 | Khosla Rachna | S · Sale | Common Stock | 2000.0 | 412.57 |
| 2026-08-07 | Busch Matthew C. | A · Grant / award | Common Stock | 730.0 | 0.0 |
| 2026-08-07 | ISHRAK OMAR | A · Grant / award | Common Stock | 85.17 | 0.0 |
| 2026-08-07 | HOLLEY CHARLES M | A · Grant / award | Common Stock | 103.42 | 0.0 |
| 2026-08-07 | Drake Michael V | A · Grant / award | Common Stock | 63.88 | 0.0 |
| 2026-08-06 | Miller Derek | S · Sale | Common Stock | 2069.0 | 402.54 |
| 2026-08-06 | Miller Derek | M · Exercise / conversion | Common Stock | 2069.0 | 162.6 |
| 2026-08-06 | Miller Derek | M · Exercise / conversion | Common Stock | 1821.0 | 177.46 |
| 2026-08-06 | Miller Derek | S · Sale | Common Stock | 1821.0 | 402.54 |
| 2026-08-06 | Miller Derek | M · Exercise / conversion | Nqso (Right to Buy) | 1821.0 | 0.0 |
| 2026-08-06 | Miller Derek | M · Exercise / conversion | Nqso (Right to Buy) | 2069.0 | 0.0 |
| 2026-08-06 | Grygiel Nancy A. | S · Sale | Common Stock | 1000.0 | 402.16 |
| 2026-08-06 | Grygiel Nancy A. | S · Sale | Common Stock | 1970.0 | 402.16 |
| 2026-08-06 | Grygiel Nancy A. | M · Exercise / conversion | Common Stock | 1970.0 | 177.46 |
| 2026-08-06 | Grygiel Nancy A. | M · Exercise / conversion | Common Stock | 1000.0 | 177.31 |
| 2026-08-06 | Grygiel Nancy A. | M · Exercise / conversion | Nqso (Right to Buy) | 1970.0 | 0.0 |
| 2026-08-06 | Grygiel Nancy A. | M · Exercise / conversion | Nqso (Right to Buy) | 1000.0 | 0.0 |
Identity & relationships
SEC issuer · 0000318154AMGEN INC
Applied Molecular GeneticsAmgen (Germany)Amgen (Netherlands)Amgen (France)
Search names and former names
View Wikidata identity and references ↗
- Amgen · alias · wikidata
- Applied Molecular Genetics · subsidiary · wikidata
- Amgen (Canada) · subsidiary · wikidata
- Amgen (Germany) · subsidiary · wikidata
- Amgen (Netherlands) · subsidiary · wikidata
- Amgen (France) · subsidiary · wikidata
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $33.42B | $35.90B |
| 2023-12-31 | $28.19B | $31.17B |
| 2022-12-31 | $26.32B | $30.30B |
| 2021-12-31 | $25.98B | $32.30B |
| 2020-12-31 | $25.42B | $33.10B |
| 2019-12-31 | $23.36B | $30.79B |
| 2018-12-31 | $23.75B | $31.86B |
| 2017-12-31 | $22.85B | $31.41B |